Eli Lilly Operating Expenses 2010-2024 | LLY

Eli Lilly operating expenses for the twelve months ending December 31, 2024 were $32.144B, a 16.18% increase year-over-year.

  • Eli Lilly annual operating expenses for 2024 were $32.144B, a 16.18% increase from 2023.
  • Eli Lilly annual operating expenses for 2023 were $27.666B, a 29.2% increase from 2022.
  • Eli Lilly annual operating expenses for 2022 were $21.414B, a 2.49% decline from 2021.

Eli Lilly Operating Expenses 2010-2024 | LLY

  • Eli Lilly annual operating expenses for 2024 were $32.144B, a 16.18% increase from 2023.
  • Eli Lilly annual operating expenses for 2023 were $27.666B, a 29.2% increase from 2022.
  • Eli Lilly annual operating expenses for 2022 were $21.414B, a 2.49% decline from 2021.
Related Stocks
Company NameMarket
Cap
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Merck (MRK)$216.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B